US Patent 10570395 Modulatory polynucleotides
Patent 10570395 was granted and assigned to Voyager Therapeutics on February, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10570395 Modulatory polynucleotides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.